Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin.

× No keyword cloud information.

55 in total

1. Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II.

Authors: Matthew Ndonwi; Oname O Burlingame; Aaron S Miller; Douglas M Tollefsen; George J Broze; Daniel E Goldberg
Journal: Blood Date: 2011-04-21 Impact factor: 22.113

2. Specificity and selectivity profile of EP217609: a new neutralizable dual-action anticoagulant that targets thrombin and factor Xa.

Authors: Steven T Olson; Richard Swanson; Maurice Petitou
Journal: Blood Date: 2011-12-05 Impact factor: 22.113

3. Zn2+ mediates high affinity binding of heparin to the αC domain of fibrinogen.

Authors: James C Fredenburgh; Beverly A Leslie; Alan R Stafford; Teresa Lim; Howard H Chan; Jeffrey I Weitz
Journal: J Biol Chem Date: 2013-08-29 Impact factor: 5.157

4. Antibodies against the activated coagulation factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin.

Authors: Yao-Hsu Yang; Kwan-Ki Hwang; John FitzGerald; Jennifer M Grossman; Mihaela Taylor; Bevra H Hahn; Pojen P Chen
Journal: J Immunol Date: 2006-12-01 Impact factor: 5.422

Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin.

1. Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II.

2. Specificity and selectivity profile of EP217609: a new neutralizable dual-action anticoagulant that targets thrombin and factor Xa.

3. Zn2+ mediates high affinity binding of heparin to the αC domain of fibrinogen.

4. Antibodies against the activated coagulation factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin.

5. Protease nexin-2/amyloid beta-protein precursor limits cerebral thrombosis.

6. Lipid oxidation inactivates the anticoagulant function of protein Z-dependent protease inhibitor (ZPI).

7. Expression and functional characterization of two natural heparin-binding site variants of antithrombin.

8. Antithrombin is protective against myocardial ischemia and reperfusion injury.

9. Vagus nerve stimulation regulates hemostasis in swine.

10. Binding of human alpha-thrombin to platelet GpIb: energetics and functional effects.